Definitive Healthcare (NASDAQ:DH) Issues FY 2024 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance of 0.360-0.380 for the period, compared to the consensus EPS estimate of 0.380. The company issued revenue guidance of $255.0 million-$261.0 million, compared to the consensus revenue estimate of $266.3 million. Definitive Healthcare also updated its Q2 2024 guidance to 0.080-0.090 EPS.

Analyst Ratings Changes

Several research firms recently weighed in on DH. Canaccord Genuity Group dropped their price objective on shares of Definitive Healthcare from $10.00 to $8.00 and set a hold rating on the stock in a research note on Wednesday. Stifel Nicolaus dropped their price objective on shares of Definitive Healthcare from $11.00 to $9.50 and set a buy rating on the stock in a research note on Wednesday. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Definitive Healthcare from $10.00 to $7.00 and set a hold rating on the stock in a research note on Thursday. Morgan Stanley lowered shares of Definitive Healthcare from an overweight rating to an equal weight rating and dropped their price objective for the stock from $11.50 to $9.00 in a research note on Wednesday. Finally, Barclays dropped their price target on shares of Definitive Healthcare from $11.00 to $7.00 and set an equal weight rating on the stock in a research note on Thursday. Nine analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, Definitive Healthcare has a consensus rating of Hold and a consensus target price of $9.94.

Definitive Healthcare Trading Down 3.4 %

Definitive Healthcare stock traded down $0.18 during midday trading on Thursday, reaching $5.17. The stock had a trading volume of 3,323,524 shares, compared to its average volume of 643,916. The firm’s fifty day simple moving average is $7.61 and its two-hundred day simple moving average is $8.27. Definitive Healthcare has a twelve month low of $4.38 and a twelve month high of $12.45. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.31 and a quick ratio of 2.31. The firm has a market cap of $608.97 million, a price-to-earnings ratio of -2.90, a PEG ratio of 6.12 and a beta of 1.41.

Definitive Healthcare (NASDAQ:DH) last posted its quarterly earnings data on Wednesday, February 28th. The company reported ($0.01) EPS for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. The firm had revenue of $65.93 million during the quarter, compared to analyst estimates of $66.01 million. Equities analysts anticipate that Definitive Healthcare will post 0.11 EPS for the current fiscal year.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.